Novel class of Fumarate Esters
We at Synovo are happy to announce our latest publication in Inflammopharmacology and with it our new class of Fumarate Esters. This […]
Category: Science
Isostearic acid and its ability to induce psoriaform lesions in murine model
We would like to share with you our latest publication and discovery on the topic of the cream-induced psoriasis murine model. In […]
News from our Infection Department
Together with our colleagues from Amsterdam and Leiden, we have taken a closer look into the antiinfective and immunomodulating effects our in-house […]
Publication Highlight: Novel JAK3 Inhibitor
One of our premier internal research projects involves the development of novel, selective inhibitors of Janus kinase 3, a compound class of […]
Latest Publications
It has been a successful year so far for our scientists in the Synovo labs with a number of publications. We are […]
One step closer
After an intense ECCMID in Madrid, surrounded by the world top initiatives in the topic of infectious diseases, we are more and […]
Our anti-microbial program has been funded
We announce funding for our breakthrough anti-microbial research program by the Netherlands NACTAR program from the Netherlands organization for Scientific Research (NWO). […]
Study 1000!!
Thanks to those who believe in us and let us participate in the development of their products by providing pharmacology services. We […]
Synovo and ophthalmology
We expand business to ophthalmologyTübingen, Germany, February 2014. Synovo, a company focused on drug discovery and preclinical development, today announced the strategic […]